Autor: |
Kadri Klaos, Anna Agejeva, Tiina Kummik, Sirje Laks, Olesja Remets, Sirje Sasi, Anneli Tann, Piret Viiklepp, Alan Altraja |
Jazyk: |
angličtina |
Rok vydání: |
2021 |
Předmět: |
|
Zdroj: |
International Journal of Infectious Diseases, Vol 104, Iss , Pp 19-26 (2021) |
Druh dokumentu: |
article |
ISSN: |
1201-9712 |
DOI: |
10.1016/j.ijid.2020.12.071 |
Popis: |
Objectives: We evaluated the performance of the MDR/XDR-TB Colour Test (CT) as an in-house thin-layer agar-based indirect drug susceptibility test (DST) for Mycobacterium tuberculosis (MTB) in a non-expert setting in Estonia. Methods: After 2 days of hands-on training for laboratory technicians, 6 panels of 150 MTB isolates were cultured onto CT plates prepared in-house in 2 laboratories. Triplicate readings of 900 CT plates resulted in 18 DST patterns for each initial isolate. Time intervals to the results and for media preparation were estimated, and intra- and interobserver agreement, test sensitivities and specificities were calculated. BACTEC MGIT 960 DST was used as a reference. Results: The median time to produce DST results for isoniazid, rifampicin and levofloxacin was 13 days. CT sensitivity was 94.7% for levofloxacin, 95.8% for isoniazid and 97.3% for rifampicin. Test specificities were >97% for all 3 drugs. Interobserver agreement was 100% in Lab A and in Lab B >97% for levofloxacin and 99% for isoniazid and rifampicin. Conclusions: The implementation of the CT into a new laboratory was straightforward with only minimal guidance required. This study proves that the CT is highly reproducible and easily interpreted by previously inexperienced personnel. |
Databáze: |
Directory of Open Access Journals |
Externí odkaz: |
|